Archive - March 2022
Novartis and Voyager Therapeutics agree on gene therapy deal worth 1.7bn
Novo Nordisk’s collaboration with MIT and BWH expanded
Study into prophylaxis treatment meets key endpoints
SMC approval welcome news for breast cancer patients
Molnupiravir: Why Are There Potential Safety Issues Around This COVID Antiviral?
Fresh Approach Needed to Tackle Addiction and Mental Health in a Post-Covid World
Study Shows Mild COVID-19 Cases May Accelerate Aging Of Brain, Other Changes
Nordic Diet Provides Health Benefits To People Even Without Weight Loss: Study